Boston Trust Walden Corp Biogen Inc. Transaction History

Boston Trust Walden Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$223.92 - $287.77 $159,878 - $205,467	-714 Closed	0 $0
Q3 2021 Oct 25, 2021	BUY	$282.99 - $369.05 $202,054 - $263,501	714 New	714 $202,000
Q1 2021 Apr 21, 2021	SELL	$242.95 - $284.63 $327,739 - $383,965	-1,349 Closed	0 $0
Q4 2020 Jan 15, 2021	BUY	$236.26 - $355.63 $4,725 - $7,112	20 Added 1.5%	1,349 $330,000
Q2 2020 Jul 23, 2020	SELL	$258.66 - $342.55 $7,759 - $10,276	-30 Reduced 2.21%	1,329 $356,000
Q1 2020 Apr 21, 2020	SELL	$268.85 - $341.04 $5,377 - $6,820	-20 Reduced 1.45%	1,359 $430,000
Q4 2019 Jan 10, 2020	SELL	$220.06 - $304.07 $28,607 - $39,529	-130 Reduced 8.61%	1,379 $409,000
Q3 2019 Oct 21, 2019	SELL	$217.44 - $243.88 $784,958 - $880,406	-3,610 Reduced 70.52%	1,509 $351,000
Q2 2019 Jul 25, 2019	SELL	$219.29 - $241.72 $196,264 - $216,339	-895 Reduced 14.88%	5,119 $1.2 Million
Q1 2019 Apr 16, 2019	SELL	$216.71 - $338.96 $8,668 - $13,558	-40 Reduced 0.66%	6,014 $1.42 Million
Q4 2018 Jan 17, 2019	BUY	$278.5 - $352.75 $959,432 - $1.22 Million	3,445 Added 132.04%	6,054 $1.82 Million
Q3 2018 Oct 23, 2018	BUY	$293.51 - $383.83 $4,402 - $5,757	15 Added 0.58%	2,609 $922,000
Q2 2018 Jul 25, 2018	SELL	$257.52 - $306.91 $25,752 - $30,691	-100 Reduced 3.71%	2,594 $753,000
Q3 2017 Oct 13, 2017	BUY	$281.15 - $329.69 $757,418 - $888,184	2,694	2,694 $844,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

Stay updated on Boston Trust Walden Corp with notifications on news.